To facilitate genetic investigations in the obligate intracellular pathogens Chlamydia, the ability to construct variants by homologous recombination was investigated in C. psittaci 6BC. The single rRNA operon was targeted with a synthetic 16S rRNA allele, harboring three nucleotide substitutions over 398 bp, which imparts resistance to kasugamycin (Ksm) and spectinomycin (Spc) and causes loss of one HpaI restriction site. A fourth, silent mutation was introduced 654 bp downstream in the beginning of the 23S rRNA gene. C. psittaci 6BC infectious particles were electroporated with various concentrations of circular or linearized plasmids containing different lengths of the rRNA region homologous to the chromosomal copy except for the four nucleotide substitutions. Ksm and Spc were added 18 h after inoculation onto confluent cell monolayers in the plaque assay. Resistant plaques were picked and expanded with selection 10 days later before collecting DNA for analysis by PCR, restriction mapping, sequencing, or Southern. Spontaneous resistance to Ksm and Spc was never observed in mock electroporated bacteria (frequency <6.2 ؋ 10 ؊9 ). Conversely, double resistance and replacement of the 16S rRNA gene were observed when C. psittaci was electroporated with the recombination substrates. Highest efficiency was obtained with 10 g of circular vector prepared in a DNA methylase-deficient Escherichia coli (1.9 ؎ 1.1 ؋ 10 ؊6 , n ‫؍‬ 7). Coinheritance of the silent 23S rRNA mutation was seen in 46 of 67 recombinants analyzed, illustrating DNA exchange of up to 1,052 bp in length. These findings provide the first step toward genetic manipulation of Chlamydia.
C
hlamydiae are obligate intracellular bacteria that cause a wide variety of infectious diseases in humans and animals (1) . C. trachomatis infections may be asymptomatic, but chronic inflammation can lead to blindness in cases of trachoma and pelvic inflammatory disease, and infertility in cases of urogenital infections. C. psittaci is the agent of avian psittacosis, but it can also cause severe pulmonary infections in humans. C. psittaci has been isolated from a wide range of wild and domesticated birds where it can produce asymptomatic or symptomatic infections with a systemic and occasionally fatal outcome. Transmission to humans results mainly in influenza-like illness, although severe pneumonia, endocarditis, myocarditis, hepatitis, and encephalitis have been reported (2) .
The ability to specifically inactivate a gene and restore the inactivated gene is central to show gene function and fulfill molecular Koch's postulates for microbial pathogenicity (3) . The complete sequencing of 11 strains of Chlamydia in the past 10 years and the rapid expansion of genomic, comparative genomic, transcriptomic, and proteomic analysis of these pathogens have created a collection of hypotheses that need to be tested through classic genetic mutation and complementation studies. However, the particular physiology of these organisms poses serious obstacles in generating the tools needed to perform genetic analysis and define the genes that are important to the biology, pathogenicity, or transmission of Chlamydia (4) . Besides long generation times and the requirement for growth within permissive cells, the developmental cycle of Chlamydia is biphasic, alternating between small, infectious, extracellular forms, the elementary bodies (EBs), and larger, noninfectious, intracellular, replicative forms, the reticulate bodies (RBs). Two to 4 hours following uptake by a host cell, EBs convert to RBs within a membrane-bound vacuole termed an inclusion. The RBs replicate by binary fission and then, 18Ϫ48 h postinfection (p.i.), depending on the species, start to redifferentiate back to EBs and exit the cell to repeat the cycle (5) .
To realize the full potential of genetic analysis of Chlamydia, it would be useful to have a means of transforming these pathogens using circular plasmids that can be easily manipulated in Escherichia coli. Almost 15 years ago, Tam et al. (6) reported transient transformation of C. trachomatis following electroporation of EBs with recombinant plasmid DNA derived from the native chlamydial cryptic plasmid. We sought to develop a stable transformation system involving homologous gene targeting, as this would allow directed mutation of the genome as well as long-term expression of introduced DNA. Such allelic replacement technology has proven extremely valuable in numerous species to selectively alter genes of interest in the host chromosome (7, 8) .
An ideal target for testing the feasibility of mutagenesis by homologous recombination in C. psittaci is its single-copy rRNA operon. We recently showed that specific mutations in the 16S rRNA or 23S rRNA genes are associated with resistance to spectinomycin (Spc) or to the clinically relevant macrolides, respectively (9, 10). Here we constructed, in E. coli, pUC plasmid derivatives carrying 8.1-, 6.5-, 5.5-, 4.8-, or 2.7-kb rRNA regions of C. psittaci 6BC, harboring 2 antibiotic resistance mutations plus 2 unselected mutations, within a 1,052-bp segment. After introduction by electroporation in the wild-type strain, we selected for allele replacement of the endogenous rRNA operon with the mutated copy from the plasmid by homologous recombination. The findings of this study provide a solid foundation toward developing DNA integration and genetic analysis tools for Chlamydia.
inhibited in vitro, in the plaque assay, by the aminoglycoside Spc. We obtained Spc R mutants at a frequency of Ϸ1 ϫ 10 Ϫ6 . These mutants resulted from single-nucleotide changes in the unique 16S rRNA gene at position 1191, 1192, or 1193 (9) . (Note: We use the E. coli numbering system throughout when referring to nucleotide(s) in rRNA genes.) We examined the in vitro sensitivity of C. psittaci 6BC for 8 additional aminoglycosides (see Materials and Methods) and found that, although streptomycin, tobramycin, and paromomycin were slightly inhibitory to the bacteria's ability to grow in L2 mouse fibroblast cells, only kasugamycin (Ksm) was efficient enough to inhibit plaque formation of 10 5 plaque-forming units (PFU) in those cells, with a minimum inhibitory concentration of 1.1 mg/mL. Spontaneous Ksm R mutants were isolated for the wild-type C. psittaci 6BC strain and the Spc R BC0E1 variant (9) with frequencies of 2.3 ϫ 10 Ϫ5 and 2.0 ϫ 10 Ϫ6 respectively (Table 1) . Analyses of the 16S rRNA gene from 24 independent Ksm R variants revealed the same A 794 G mutation previously isolated in a Ksm R strain of E. coli expressing a single rRNA operon (11) . When Ksm resistance was selected in BC0E1, both the Ksm R A 794 G mutation and the original Spc R C 1192 T mutation were identified in the 16S rRNA gene, indicating no antagonism between the 2 resistance mutations. No plaques were recovered when up to 10 8 wild-type parental cells were infected in the plaque assay in the presence of both Spc and Ksm (Table 1 ). This suggests that spontaneous mutations to dual resistance occur at an undetectable frequency. Consequently, we chose the rRNA operon from the Ksm R Spc R C. psittaci 6BC BCKS1 isolate [supporting information (SI) Table S1] as the source for the selective marker for allelic exchange.
Construction of the rRNA Operon-Based Selection Vector for C. psittaci. pRAK407 ( Fig. 1) was created from 6 different PCR amplifications, clonings, and sequencings and 5 subclonings (Table  S1 ). It is a pUC derivative carrying the chloramphenicol resistance cat gene for selection in E. coli and the double Ksm Spc-resistant 16S allele of C. psittaci 6BC together with 3 kb DNA upstream and 3.5 kb downstream from the mutated 16S rRNA gene. An additional mutation, A to G, was created during the construction of pRAK407 at position 72 in the beginning of the 23S rRNA gene, 654 bp downstream of the Spc R mutation. Although this nucleotide is highly conserved in Chlamydia and in E. coli (Fig. S1 A) , its importance in bacterial physiology has not been characterized.
Sequence alignment of the 16S rRNA genes available in GenBank for 42 different strains of C. psittaci revealed a natural heterogeneity in the nucleotide at position 1071: 25 strains, including strain 6BC, harbor a C, whereas the remaining 17 possess a T (Fig. S1B) . We introduced the C 1071 T mutation into the 16S Ksm Spc-resistant C. psittaci 6BC allele to create pRAK426 (Fig. 1 ). This mutation is not expected to affect the bacterial physiology once introduced into C. psittaci 6BC; however, it disrupts the HpaI GTTAAC 1071 restriction site and thus provides a powerful tool to analyze the recombinants.
Optimization of Electroporation for C. psittaci 6BC. All genetic systems for the disruption of chromosomal loci depend on the ability to deliver DNA into the bacterial cell. Consequently, we sought to optimize electroporation conditions to introduce DNA into EBs, the small (Ϸ0.3 m in diameter), environmentally stable chlamydial infectious particles with a condensed nucleoid structure protected by a rigid cell wall. PCR (data not shown) and comparative qPCR ( Table 2 ) analyses show that a foreign marker became protected from extracellular DNase digestion after electroporation with C. psittaci 6BC EBs. We found that the amount of DNA The frequency of mutation to drug resistance was determined by dividing the number of PFU on medium with drug by the number of PFU added to the monolayer (as measured by PFU titer in the absence of drug) (9, 10) . See Table S1 surviving DNase treatment increased when higher time constants were obtained, being 2 10 -fold (Ϸ1,000-fold) greater, with 2 pulses of 12.8 ms each, than in the absence of electroporation (Table 2) . Because longer exposure to high-voltage fields resulted in greater DNA introduction, we used 2 pulses at 1.6 kV, 600 ⍀, and 25 F in all chlamydial electroporation assays. These conditions reduced bacteria viability by only Ϸ2-fold (Table 2) .
Isolation and Molecular Analysis of the Double Spc R Ksm R C. psittaci
Recombinants. Initial experiments used pRAK407 and pRAK426 DNA to transform C. psittaci. Following electroporation, C. psittaci 6BC EBs were diluted in 1ϫ Dulbecco's Modified Eagle Medium (DMEM; GIBCO) and used to infect confluent monolayers of L2 mouse fibroblasts in the plaque assay (9) . Both 300 g/mL Spc and 3 mg/mL Ksm were added at 18 h p.i., before RBs started conversion back to EBs (12) . We observed that the monolayer was able to tolerate infection with 10 7 EBs under such conditions, corresponding to a multiplicity of infection of 1. Between 10 and 14 days p.i., resistant plaques were picked and expanded again in the plaque assay with drug selection at 2 h p.i. Total DNA was prepared from infected cells when plaques started to appear, or at 10 days p.i., and further analyzed (Fig. S2 ). The chromosomal 16S rRNA gene and its upstream region were specifically amplified from a total of 329 individual Ksm R Spc R plaques that expanded with selection, using the 16S-R1 and the FtsK-R9 primers ( Fig. 1 and Table S2 ). FtsK-R9 anneals to ftsK in a region that is not included in the transformation allele. This strategy precludes amplification of episomal or illegitimately integrated plasmids and allows only the amplification of DNA from the chromosomal rRNA locus. Sequencing of the 16S rRNA gene in 37 recombinants showed the presence of the 2 resistance mutations at position 794 and 1192, as expected from the dual-resistance phenotype. HpaI restriction mapping in each 16S rRNA region PCR product from 329 recombinants derived from pRAK426 revealed the absence of a 415-bp fragment (Figs. 1 and 2A) , indicating the coinheritance of the C 1071 T mutation resulting in the disruption of one HpaI restriction site in the chromosomal 16S rRNA allele. Southern blot analysis of highly purified genomic DNA from the parent BC RB and 4 independent pRAK426-derived recombinants also confirmed the lack of one HpaI site in the recombinant 16S rRNA gene (Fig. 2B) . The 18 recombinants derived from pRAK407 showed conservation of the HpaI site (e.g., Fig. 2 A, lane 12) . The presence of only a single SacII fragment in the recombinants also excludes the possibility that the transformation plasmid had integrated into the chromosome, because such an event would have produced multiple hybridizing bands. For 328 recombinants analyzed, the phenotypes imparted by the 3 marker nucleotides at positions 794, 1071, and 1192 in the 16S rRNA gene indicated that DNA replacement occurred over a minimum of 398 bps.
Relationship between Recombination Frequency and Physical State of the Recombination Substrate. In a typical transformation experiment starting with 10 7 C. psittaci EBs, Ϸ5 ϫ 10 6 PFU survived electroporation. Transformation with a minimum of 10 g of circular or NotI-linearized plasmid that separated the chlamydial rRNA region from the vector backbone produced recombinants at a frequency Ϸ10 Ϫ6 (Table S3 and Table 3 ). However, the assay was much less reproducible when linear DNA was used, because electroporation was frequently accompanied by arcing or a poor time constant, resulting in elevated bacterial killing. Consequently, we never recovered more than 2 resistant plaques per transformation with NotI-linearized plasmid (Table S3 ). The DNA of E. coli K-12 contains modified bases (6-methyladenine and 5-methylcytosine) resulting from the action of 3 DNA methyltransferases, EcoK (encoded by the hsd host specificity genes), Dam, and Dcm (13) . Although analysis of the sequences available for 10 different chlamydial genomes yielded ORFs with predicted methyltransferase motifs, none appeared directed against DNA, suggesting that DNA in Chlamydia is not modified. Restriction analysis of the native chlamydial plasmid using methylationsensitive enzymes showed that C. trachomatis L2 DNA is not methylated in vivo (data not shown). The recombination donor plasmid prepared in an E. coli host that was mutated in all 3 DNA methylase genes-hsdS, dcm, and dam-was a slightly better substrate for recombination, as we obtained up to 14 recombinants per transformation with 10 or 20 g of circular unmethylated plasmid, for a recombination frequency close to 3.0 ϫ 10 Ϫ6 (Table S3 and  Table 3 ).
Defining the Minimal Length of Sequence Homology Required for
Homologous Recombination in C. psittaci 6BC. To determine the minimum size of DNA necessary for homologous recombination in C. psittaci 6BC, we constructed a set of derivatives from the initial pRAK426 construct harboring various deletions 5Ј and/or 3Ј to the 16S rRNA double-resistance allele (Fig. 1) . The recombination frequency, which is dependant on both the number of recombinants and the number of EBs that survived electroporation, varied from the limit of detection (Ϸ0.4 ϫ 10 Ϫ6 ) to Ϸ2 ϫ 10 Ϫ6 , depending on the construct. We saw a drop in the number of recombinants obtained when the flanking regions were reduced to Ͻ2.0 kb of strict homology, although higher amounts of unmethylated plasmid could compensate for shorter lengths of homology to some extent ( Table 3) .
The A-to-G single nucleotide polymorphysm (SNP) located in the recombination plasmid at position 72 of the 23S rRNA gene allowed us to extend our analysis on the length of DNA that recombined into the C. psittaci 6BC genome. This SNP lying 1,052 and 654 bps downstream to the Ksm R and the Spc R mutations, respectively, was coinherited with both 16S rRNA resistance mutations in 46 of 67 independent recombinants, showing DNA exchange over a region up to 1,052 bps in length. Acquisition of this 23S rRNA mutation seemed also dependant on the size of homology flanking the nucleotide mutation. Nonetheless, there was 75% coinheritance with only 1.6 kb of flanking DNA (Table 3) . One recombinant from pRAK423 carried the A 72 G mutation in the 23S rRNA, but showed in its 16S rRNA gene only the 2 antibioticresistant mutations and not the intervening C 1071 T allele. This finding was unexpected and probably due to gene conversion (see Discussion).
Fate of the Circular Recombination Substrate. The hybridization analysis of highly purified genomic DNA did not reveal the presence of multiple 16S rRNA gene copies in the recombinants (Fig. 2B) , nor were we able to detect the recombination vector using a probe directed against the cat gene (Fig. 2C) . This indicates that the recombination substrate was not maintained and did not integrate into the recombinant chromosome. However, ectopic expression of the Ksm R Spc R 16S rRNA allele could in theory confer some level of resistance to C. psittaci, because expression of resistance linked to mutated rRNA genes requires that a majority of the cellular rRNA be of the mutant form (14) . Three recombinants of the 329 obtained still showed the presence of the pUC derivative by PCR amplification of the cat marker in infected cell lysates prepared 18 days posttransformation (data not shown), and we were able to recover the recombination plasmid intact by transformation into E. coli EC100. Yet sequence analysis of the chromosomal ribosomal operon did not show the presence of the parental 16S rRNA allele. Southern blot hybridization of 2 of the recombinants using the cat probe and the 16S probes confirmed that the recombination plasmid was indeed episomal and not integrated somewhere in the bacterial chromosome (Fig. S3) . Serial dilution of the third recombinant and additional passage in cell culture in the presence of drug resulted in loss of the plasmid 25 days posttransformation, illustrating the instability of the pUC replicon in C. psittaci 6BC.
Stability of the Allelic Exchange in C. psittaci 6BC Recombinants. Six independent recombinants, including 3 with the 23S rRNA A 72 G SNP, were purified in the plaque assay 11 days posttransformation and then expanded with drug selection for 6 additional days (Fig.  S2 ). All 6 gave similar titers in the plaque assay in the presence or absence of selection. Plaques were further grown for 8 days in the absence of selection, then picked and expanded in the absence of selection for 6 more days (Fig. S2) . The quantity of EBs contained in each final culture was similar in the presence or absence of selection, confirming the stability of the Ksm R and Spc R phenotypes. We then purified and expanded 8 plaques that developed in the absence of selection for each of the 6 recombinants for DNA analysis (Fig. S2) . The nucleotides at positions 794, 1071, and 1192 in the 16S rRNA gene and 72 in the 23S rRNA gene were identical to those seen in the original recombinant, showing that the DNA exchange between the recombination vector and the bacterial genome led to stable transformation of C. psittaci 6BC.
Discussion
Progress in exploiting chlamydial genome information has been severely impeded by the complete lack of genetic tools for the directed manipulation of specific genes in these obligate intracellular Gram-negative pathogens (4). Although interstrain, intergenic, and intragenic recombination has been proposed to generate sequence variations in chlamydiae (15, 16) , this study proves that recombinant DNA can be introduced into C. psittaci 6BC and promote recombination/exchange of ''heterologous'' DNA sequences into the bacterial chromosome.
Our findings show that a high electric field (i.e., 16 kV/cm) for Ϸ13 ms was optimal for DNA introduction into C. psittaci 6BC ( Table 2 ). Similar conditions were optimal for C. trachomatis L2 (data not shown). Small cells such as chlamydial EBs generally require high electric fields for successful transformation, and similar conditions have been reported to be efficient for Coxiella burnetii transformation (17) . Tam et al. (6) used 10.0 kV/cm, 400 ⍀, and 25 F in their electroporation protocol but reported poor postelectroporation recovery for C. trachomatis L2. In our study, viability of C. psittaci 6BC (Table 2) or C. trachomatis L2 (data not shown) was reduced by less than 3-fold as long as both DNA and EBs were resuspended in water without salt or other impurities. Consequently, we propose that the main factor responsible for the higher bacterial killing observed by Tam et al. (6) was probably the use of an electroporation buffer composed of sucrose, Hepes, and glycerol.
A challenge in the development of genetic tools for Chlamydia is that only a few antibiotic resistance determinants can be used. Deliberate introduction of genes conferring resistance to drugs used to treat chlamydial infections, such as tetracyclines, macrolides, fluoroquinolones, or amoxicillin (18), is restricted. The obligate intracellular lifestyle of these pathogens poses an additional challenge because an efficient antichlamydial drug must cross 4 permeability barriers (i.e., eukaryotic, inclusion, and outer and inner membranes) to reach the bacterial target. Although aminoglycosides are considered clinically inactive against obligate intracellular bacteria due to their low level of intracellular penetration, we found that both Spc and Ksm were inhibitory for C. psittaci in the plaque assay. We isolated spontaneous drug-resistant variants due to specific mutations in the unique 16S rRNA gene. Because expression of aminoglycoside resistance requires that Ͼ50% of the ribosome population be of the resistant phenotype, similar mutations conferring resistance to Spc or Ksm could not be isolated in C. trachomatis L2, which harbors 2 rRNA operons (9) .
The transformation/recombination system described in this study allows us to introduce desired mutations into the single-copy rRNA gene of C. psittaci 6BC using a plasmid that contains a fragment of C. psittaci DNA containing the entire rRNA operon, including the selective markers in the 16S rRNA gene, which serves as the recombination substrate. The pUC backbone permits high-copy vector replication in E. coli and renders possible the application of standard genetic engineering and in vitro mutagenesis techniques. ColE1-type plasmids such as pUC are narrow host-range plasmids that replicate stably only in enterobacteriaceae (19) . Consequently, they should behave like a suicide plasmid in Chlamydia, helping to promote selection of recombinants (20) . We were still able to detect the recombinant vector, in its original configuration, in 3 recombinants at 18 days p.i., and, in at least 1 recombinant, the plasmid was still detected in infected cells at 25 days posttransformation. Although this represents less than 1% of C. psittaci recombinants, these data suggest a basic level of replication/maintenance in C. psittaci 6BC, similar to Legionella pneumophila in which ColE1 plasmids can be maintained under antibiotic selection, with lowcopy number and instability (21) . In our study, selection of transformants was applied only at 18 h p.i., corresponding to about 10 bacterial generations (12) , and would not be sufficient to maintain extrachromosomal plasmids once the marker has recombined into the chromosome. Additional studies are thus necessary to confirm possible replication and maintenance of pUC vectors in Chlamydia.
Several features of our transformation strategy allow us a high degree of confidence in concluding that we recovered genetically modified, recombinant C. psittaci 6BC. (i) Because Spc and Ksm resistance are recessive in a merodiploid strain, expression of the resistance phenotype requires elimination of the wild-type gene (by gene replacement). This constraint precludes selection of events in which the circular vector would have integrated within the target sequence by single-crossover homologous recombination. Our analysis shows that the only cells that survive under the selective growth conditions were those in which the mutated region in the plasmid borne rRNA operon replaced the corresponding region of the chromosomal rRNA operon. This plasmid-to-chromosome allelic exchange is accompanied by loss of the plasmid vector and results in the transformed cells having a single copy of the rRNA operon carrying the selected mutations. (ii) Two nucleotide substitutions, 398 bp apart, are present in the C. psittaci 16S rRNA gene on the recombinant plasmids to promote resistance to the 2 ribosomal drugs Ksm and Spc. The use of 2 antibiotic-resistance markers in the vector is essential for selecting authentic transformants and for distinguishing them from single spontaneous point mutants. The latter appear with high frequencies when selected on either Ksm (Ϸ10 Ϫ5 ) or Spc (Ϸ10 Ϫ6 ). However, because 2 independent mutations must occur spontaneously within the same cell to render it resistant to both antibiotics, the frequency of such events should be vanishingly low (Ϸ10 Ϫ11 ) such that only true transformants would grow in the presence of both drugs. (iii) The incorporation of 2 additional nucleotide changes that have never been described in C. psittaci 6BC into our recombination substrate further excluded the possibility for spontaneous emergence of a mutant harboring the Spc R and Ksm R alleles, as well as these 2 unselected alleles.
Recombinants were obtained at frequencies greater than 10 Ϫ6 . Efficiency of homologous recombination was dependent on the size of the homologous DNA segments in the plasmid and chromosome. When the plasmid borne rRNA-encoding segment was reduced from 8 kb to 2.5 kb, the efficiency of transformation/recombination dropped almost 10-fold. The exact size of the plasmid DNA fragment that recombines into the chromosome is unknown, but it lies between a minimum of 0.4 kb (the distance between the 2 Ksm R and Spc R markers) to a maximum confirmed size of 1 kb (the distance between the Ksm R marker and the unselected mutation in the 23S rRNA gene). However, the size could formally be as large as 8 kb, the largest plasmid-borne rRNA fragment used in this study.
Homologous recombination has a central role in the repair of DNA double-strand breaks, interstrand crosslinks, and collapsed replication forks and involves the exchange of strands between 2 homologous DNA molecules catalyzed by the RecA family of ATPases, conserved from bacteria to humans (22, 23) . The exact mechanism of sequence replacement observed in this study is not known as it could involve reciprocal recombination via 2 successive crossovers (i.e., true allelic exchange) or nonreciprocal recombination via gene conversion (i.e., allelic replacement) that does not always involve crossovers but does require DNA synthesis. In 1 recombinant, we did not see transfer of the mutation located in between the 2 resistance mutations to the bacterial chromosome. Similar recombinants, displaying 2 tracts of continuous gene replacement with a marker or two between these tracts that did not show sequence replacement, have been previously observed in Rhizobium etli (24) . It was speculated that rather than emerging from a rare quadruple crossover, these discontinuous sequence transfers more likely resulted from gene conversion.
In this study, we selected for the occurrence of homologous recombination events with the intent of developing methods for
